Available to sourceHuman Prescription DrugGastrointestinal

0.9% SODIUM CHLORIDE

9 mg/mL · Injection Solution

By HF Acquisition Co LLC, DBA HealthFirst

NDC: 51662-1359
Route: Intramuscular; Intravenous; Subcutaneous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: NDA

Package sizes

50 mL in 1 VIAL, PLASTIC (51662-1359-1)NDC 51662-1359-1Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.